|
Quotes & Info
|
| ZLCS > SEC Filings for ZLCS > Form 8-K on 10-Sep-2012 | All Recent SEC Filings |
10-Sep-2012
Other Events, Financial Statements and Exhibits
On September 10, 2012, Zalicus Inc. ("Zalicus") issued a press release announcing the results of a Phase 2b clinical trial evaluating Synavive in patients with rheumatoid arthritis. The full text of Zalicus's press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
(d) Exhibits
Exhibit No. Description
99.1 Press release of Zalicus Inc. dated September 10, 2012.
|
|